InsidersTradesSigma
Vitrolife AB: directors' dealings · Finland · FIN-FSA
FI:vitrolife-abSE0011205202FI·FIN-FSAMcap 14.1Bn€Healthcare
Explore the full insider trade history of Vitrolife AB, a listed issuer based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Vitrolife AB has recorded 3 insider filings. Market capitalisation: €14.1bn. The latest transaction was filed on 6 February 2026 (Purchase). Among the most active insiders: Bronwyn Brophy O'Connor. Every trade is openly available.
3
Insider Decl.
0
Thresholds
€98,038
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
104.30 €
Analyst consensus
4 analystsStrong buy
131.00 €Target 162.75 €(+56%)215.00 €
Income statement
Revenue3.44 Bn€
Gross profit2.00 Bn€58% margin
Net income−5.01 Bn€-147.2% margin
Valuation
PER (forward)18.2x
P/Book1.8x
Beta1.73
Balance sheet & cash
Market cap14.13 Bn€
Total debt1.60 Bn€
Free Cash Flow388.0 M€
Debt / Equity20%
Profitability & ownership
ROE-47.3%
ROA2.6%
% insiders29.7%
% institutions55.7%
Last declaration on 6 February 2026
Declarations3 total
Executives●Purchase36FIN-FSA
€25,2623,013 shares@ €8.38450.0002% mcap100.0% of flow
Aktie
FI:A003V712-1·
Ideal exit: 3 Nov 2026 (T+270)
Executives●Purchase25FIN-FSA
€54,0846,470 shares@ €8.35920.0004% mcap100.0% of flow
Aktie
FI:A003V709-1·
Ideal exit: 3 Nov 2026 (T+270)
Executives●Purchase33FIN-FSA
€18,6922,200 shares@ €8.49610.0001% mcap100.0% of flow
Aktie
FI:A003V642-1·
Ideal exit: 1 Nov 2026 (T+270)
3 of 3 declarations